Affiliation:
1. Diagnostic Laboratory, James A. Baker Institute for Animal Health, Cornell University, Ithaca, New York 14853, USA.
Abstract
Twenty-two specific-pathogen-free beagles were vaccinated with recombinant OspA (ospA gene derived from Borrelia burgdorferi B31) alone or with adjuvant (QuilA, Montanide ISA25, or aluminum hydroxide) at 6 weeks of age. Thirteen dogs were used as nonvaccinated controls with or without adjuvant. Three dogs were kept as contact controls and received neither vaccine nor challenge. Six weeks or 6 months after the first vaccination, the vaccinated (20 of 22) and nonvaccinated dogs (13) were challenged by exposure to adult ticks (Ixodes scapularis) naturally that were infected with B. burgdorferi (tick infection rate, > or = 60%) and that were collected from Westchester County, N.Y. Protection from infection was evaluated by culture for B. burgdorferi from skin biopsies taken near the sites of tick bites. Skin biopsies were taken at monthly intervals for 3 months. B. burgdorferi was not isolated from any of the vaccinated dogs. In contrast, 12 of 13 control dogs challenged by exposure to the ticks were culture positive. The histopathology of the joint capsules 3 months after the challenge was used to evaluate protection from arthritis. Eight of 13 control dogs showed synovitis in single or multiple joints, while only 1 of the 22 vaccinated dogs had a single focus of mild inflammation in a single joint. At the time of the challenge, the vaccinated dogs had antibody to B. burgdorferi, which was demonstrable by kinetic enzyme-linked immunosorbent assay, Western blotting (immunoblotting), and a serum growth inhibition assay. The vaccinal antibody declined gradually after the challenge, especially in dogs vaccinated with OspA without adjuvants. Antibodies in the challenge control dogs were only detectable by 4 to 6 weeks after the challenge and remained at high levels until the termination of the study. Contact control dogs showed no antibody responses or histopathologic lesions and were culture negative. By Western blot analysis, antibodies to OspA first appeared in the sera of vaccinated dogs 3 weeks after the first vaccination. The absence of additional bands after the challenge suggests that infection in vaccinated dogs was blocked. Results from this study show that vaccination with recombinant OspA protected dogs against infection and disease after an experimental challenge with B. burgdorferi by exposure to ticks.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Immunology,Microbiology,Parasitology
Reference49 articles.
1. Epizootiology of Borrelia in Ixodes tick vectors and reservoir hosts;Anderson J. F.;Rev. Infect. Dis.,1989
2. Experimental Lyme borreliosis in dogs produces arthritis and persistent infection;Appel M. J.;J. Infect. Dis.,1993
3. Appel M. J. G. Y. F. Chang R. H. Jacobson S. J. Shin L. A. Patrican B. A. Summers and R. K. Straubinger. 1994. Protection of SPF dogs from experimental infection and disease with Borrelia burgdorferi by immunization with OspA p. 119-122. In R. Cevenini V. Sambri and M. La Placa (ed.) Advance in Lyme borreliosis research. Proceedings of the VIth International Conference on Lyme Borreliosis. 19 to 22 June 1994 Bologna Italy.
4. Delineation of Borrelia burgdorferi sensu stricto, Borrelia garnii sp. nov., and group VS461 associated with Lyme borreliosis;Baranton G.;Int. J. Syst. Bacteriol.,1992
5. Burgess E. C. 1988. Borrelia burgdorferi infection in Wisconsin horses and cows p. 235-243. In J. L. Benach (ed.) Lyme disease and related disorders. The New York Academy of Sciences New York.
Cited by
75 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献